Header Logo

Connection

GRACE LO to Prostatic Neoplasms, Castration-Resistant

Back to Details
This is a "connection" page, showing publications GRACE LO has written about Prostatic Neoplasms, Castration-Resistant.
GRACE LO
Connection Strength
0.160
Prostatic Neoplasms, Castration-Resistant
  1. Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial. Ann Oncol. 2021 07; 32(7):896-905.
    View in: PubMed
    Score: 0.160
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.